HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Diphenhydramine Hydrochloride

HCID 8980
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
147-24-0
Standard SMILES
CN(C)CCOC(c1ccccc1)c1ccccc1.Cl
InChIKey
PCHPORCSPXIHLZ-UHFFFAOYSA-N
Molecular formula
C17H21NO.ClH
Average molar mass
291.8 g/mol
Monoisotopic mass
291.138992

Overview

Diphenhydramine hydrochloride appears as white or almost-white crystalline powder. Odorless with a bitter numbing taste. pH (5% aqueous solution) 4-6. (NTP, 1992)

Names & identifiers

Preferred name
Diphenhydramine Hydrochloride
IUPAC
2-benzhydryloxy-N,N-dimethylethanamine;hydrochloride
English name
Diphenhydramine Hydrochloride
Molecular formula
C17H22ClNO
Molecular weight
291.82

Names & synonyms

DIPHENHYDRAMINE HYDROCHLORIDE147-24-0Diphenhydramine HClAllergivalBendylateAntitussiveDenydrylEldadrylFenylhistHydramineDibenilSilphen
Show more names
BAXDiphenhydramine HCIBenylinBenacineAmbenylActifedDIMEDROLUMBENADRYL HCLcomponent of Caladryl
BeldinBelixDiphenDiphenhydramine.HClFelbenBenaDimedrol hydrochlorideHalbmond

Database identifiers

CAS
147-24-0
PubChem CID
8980
DTXSID
DTXSID4020537
ChEMBL
CHEMBL1620
UNII
TC2D6JAD40
EC Number
205-687-2

Properties

Computed structural properties

Topological polar surface area
12.5 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
6
Heavy atoms
20
Formal charge
0
Complexity
211

Experimental & physicochemical properties

Chemical ClassesPharmaceutical
Solubility · 2 items

greater than or equal to 100 mg/mL at 70.7 °F (NTP, 1992)

>43.8 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 3 items

Breast Feeding; Lactation; Milk, Human; Antihistamines

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Melting Point331 to 338 °F (NTP, 1992)
Physical DescriptionDiphenhydramine hydrochloride appears as white or almost-white crystalline powder. Odorless with a bitter numbing taste. pH (5% aqueous solution) 4-6. (NTP, 1992)
Collision Cross Section162.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
168 · 168-172 °C
Boiling point
163 · 163-167 °C(Press: 3 Torr)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Warning

H302 (99.1%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 221 reports by companies from 7 notifications to the ECHA C&L Inventory.

Danger

H302: Harmful if swallowed [Warning Acute toxicity, oral]

Hazard information

Regulatory InformationDiphenhydramine hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - Ethanamine, 2-(diphenylmethoxy)-N,N-dimethyl-, hydrochloride: Environment tier I assessment
Fire HazardsFlash point data for this chemical are not available; however, it is probably combustible. (NTP, 1992)
Health Hazards · 1 item

SYMPTOMS: Symptoms of exposure to this compound may include photosensitivity, hypotension, headache, hemolytic anemia, dizziness, disturbed coordination, nervousness, tremor, insomnia, blurred vision, tinnitus, epigastric distress, nausea, vomiting, diarrhea, constipation and tightness of the chest. Other symptoms may include anaphylactic shock, fatigue, confusion, restlessness, euphoria, diplopia, urinary frequency, drowsiness, urticaria, drug rash, excessive perspiration, chills, dryness of the mouth, nose and throat, palpitations, tachycardia, extrasystoles, thrombocytopenia, agranulocytosis, sedation, excitation, irritability, paresthesia, acute labyrinthitis, neuritis convulsions, anorexia, difficult urination, urinary retention, early menses, thickening of bronchial secretions, wheezing and nasal stuffiness. Other symptoms may include inability to concentrate, muscular weakness, nightmares, difficulty in micturition, elation, depression, hyperpyrexia, muscle twitching lassitude, tingling, heaviness, and weakness of hands. Overdosage reactions may include atropine-like symptoms, dry mouth, fixed and dilated pupils, flushing, gastrointestinal symptoms, central nervous system depression to stimulation, hallucinations, convulsions and death.

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

Hepatic and renal Route of Elimination: Little, if any, is excreted unchanged in the urine; most appears as the degradation products of metabolic transformation in the liver, which are almost completely excreted within 24 hours. Half Life: 1-4 hours

FDA Pharmacological Classification · 6 items

ALLERGY DYEFREE

Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]

DIPHENHYDRAMINE HCI

Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]

DIPHENHYDRAMINE HCL

Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]

MeSH Pharmacological Classification · 6 items

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.

Drugs used to prevent NAUSEA or VOMITING.

Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS.

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

Related reactions

2 records
New reaction record
HRID 890919 reaction equation
HRID 890919As reactant
HRID 2232939 reaction equation
HRID 2232939As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Density
1.0489 · 1.0489 (rough estimate)
refractive index
1.58 · 1.5800 (estimate)
Flash point
9 ℃ · 9℃
storage temp.
2 · 2-8°C
solubility
Very soluble in water, freely soluble in alcohol.
form
Crystalline Powder or Adhering Crystals
color
White
PH
pH(100g/L, 25℃) 4.0~5.5
Water Solubility
1000 g/L · 1000 g/L
Sensitive
Light Sensitive
Merck
14 · 14,3309
Stability
Stable, but slowly darkens upon exposure to light. Incompatible with strong oxidizing agents.
Cosmetics Ingredients Functions
HAIR CONDITIONINGSKIN CONDITIONING
InChI
1S/C17H21NO.ClH/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;/h3-12,17H,13-14H2,1-2H3;1H
InChIKey
PCHPORCSPXIHLZ-UHFFFAOYSA-N
SMILES
Cl[H].CN(C)CCOC(c1ccccc1)c2ccccc2
LogP
3.662 · 3.662 (est)
Toxicology and Carcinogenesis
Toxicology and Carcinogenesis Studies of Diphenhydramine Hydrochloride (CASRN 147-24-0) in F344/N Rats and B6C3F1 Mice (Feed Studies)
FDA 21 CFR
310.545 · 310.545; 336.10; 338.10;341.12; 341.14
CAS DataBase Reference
147 · 147-24-0(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
2 D6JAD40 · TC2D6JAD40
NCI Drug Dictionary
diphenhydramine hydrochloride
NIST Chemistry Reference
diphenhydramine hydrochloride(147-24-0)
EPA Substance Registry System
Diphenhydramine hydrochloride (147-24-0)
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302
Precautionary statements
301 · P301+P312+P330
PPE
95 · dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Hazard Codes
Xn,T,F
Risk Statements
22 · 22-39/23/24/25-23/24/25-11
Safety Statements
36 · 36-45-36/37-16-7-24/25
RIDADR
2811 · 2811
WGK Germany
3 · 3
RTECS
7000000 · KR7000000
HS Code
29221990 · 29221990
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 Oral · Acute Tox. 4 Oral
Toxicity
50 orally · LD50 orally in rats: 500 mg/kg (Gruhzit, Fisken)
Reactive GroupEthers
Reactivity ProfileDIPHENHYDRAMINE HYDROCHLORIDE gives acidic solutions in water. Neutralizes bases. May react with strong oxidizing and strong reducing agents. May catalyze organic reactions. Slowly darkens on exposure to light.
Air and Water ReactionsWater soluble. Aqueous solutions are acidic.
Hazard Classes and Categories · 2 items

Acute Tox. 4 (99.1%)

Acute toxicity (Oral) - Category 4

Safety & protection

Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1 item

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 item

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Personal Protective Equipment (PPE) · 1 item

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Toxicology

Treatment · 1 item

There is no specific antidote for diphenhydramine toxicity, but the anticholinergic syndrome has been treated with physostigmine for severe delirium or tachycardia. Benzodiazepines may be administered to decrease the likelihood of psychosis, agitation, and seizures in patients who are prone to these symptoms.

Health EffectsThey cause slurred speech, disorientation and "drunken" behavior. They are physically and psychologically addictive.
Exposure RoutesOral; topical ; parenteral(intramuscular or intravenous injection). Quickly absorbed with maximum activity occurring in approximately one hour.
Toxicity SummaryDiphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding.
Signs and SymptomsConsiderable overdosage can lead to myocardial infarction (heart attack), serious ventricular dysrhythmias, coma and death.
Carcinogen Classification · 6 items

Diphenhydramine Hydrochloride

TR-355: Toxicology and Carcinogenesis Studies of Diphenhydramine Hydrochloride (CASRN 147-24-0) in F344/N Rats and B6C3F1 Mice (Feed Studies) (1989 )

10/03/88

Equivocal Evidence

Equivocal Evidence

No Evidence

Drug Induced Liver Injury · 6 items

Drug Induced Liver Injury Rank (DILIrank 2.0)

Diphenhydramine hydrochloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataLD50: 500 mg/kg (Oral, Rat) (A308)
USGS Health-Based Screening Levels for Evaluating Water-Quality · 3 items

Diphenhydramine

Pharmaceutical

Smith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP

Safety data

PPE
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
wgk
3
rtecs
KR7000000
ridadr
2811
hs_code
29221990
Toxicity
LD50 orally in rats: 500 mg/kg (Gruhzit, Fisken)
risk_code
22-39/23/24/25-23/24/25-11
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn,T,F
safety_code
36-45-36/37-16-7-24/25
Storage Class
11 - Combustible Solids
Hazard statements
H302
Hazard Classifications
Acute Tox. 4 Oral
Precautionary statements
P301+P312+P330

Uses & manufacturing

UsesFor the treatment of symptoms associated with Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite.
Applications · 4 items

DescriptionDiphenhydramine hydrochloride is an antihistamine drug having the chemical name 2-(Diphenylmethoxy)- N,N-dimethylethylamine hydrochloride. It occurs as a white, crystalline powder, is freely soluble in water and alcohol and has a molecular weight of 291.82. The molecular formula is C17H21NO·HCl and the structural formula is as follows: Diphenhydramine hydrochloride in the parenteral form is a sterile, pyrogen-free solution available in a concentration of 50 mg of diphenhydramine hydrochloride per mL. The solutions for parenteral use have been adjusted to a pH between 5.0 and 6.0 with either sodium hydroxide or hydrochloric acid and contains 0.1 mg/mL benzethonium chloride as a germicidal agent.

DescriptionDiphenhydramine is most commonly used as a first-generation antihistamine and is globally marketed in various brand formulations (Benadryl®, Unisom®, Tylenol®, Zzzquil®). It competitively blocks H1 receptors, thereby preventing the actions of histamine on bronchial smooth muscle, capillaries, and gastrointestinal (GI) smooth muscle. This prevents histamine-induced bronchoconstriction, vasodilation, increased capillary permeability, and GI smooth muscle spasms. Diphenhydramine exhibits anti-tussive, antiemetic, sedative, anti-allergic, and anticholinergic activities.

UsesDiphenhydramine is a H1-histamine receptor antagonist with anticholinergic (drying) and sedative side effects. It is categorized as an antihistaminic; sedative, hypnotic, treatment of allergic. It is used to treat allergy and cold symptoms such as sneezing, runny nose, watery eyes, urticaria (hives), skin rash, and pruritus (itchy skin).

General DescriptionDiphenhydramine hydrochloride(Benadryl), is an oily, lipid-soluble free base available as the bitter-tasting hydrochloride salt, which is a stable, White or almost-white crystalline powder. Odorless with a bitter numbing taste. soluble in water (1:1), alcohol (1:2) and chloroform (1:2). The salt has a pKa value of 9, and a 1% aqueous solution has a pH of about 5.

Preparation methods · 1 item

PreparationDiphenhydramine Hydrochloride synthesis is a four-step sequence starting with a Grignard reaction. Synthesis of Diphenhydramine Hydrochloride 6.A) modified synthetic route to diphenhydramine hydrochloride.B) Sequence of unit operations required for the synthesis. The dotted boxes denote the four stages of the synthesis. DMAE: dimethylaminoethanol.Organic synthesis in a modular robotic system driven by a chemical programming language

Upstream & downstream products

Upstream raw materials

Sodium carbonateDiphenylmethaneDiphenhydramineEthanolHydrochloric acid

Additional notes

DefinitionChEBI: Diphenhydramine Hydrochloride is the hydrochloride salt form of diphenhydramine, an ethanolamine and first-generation histamine antagonist with anti-allergic activity.